FindTrial
Sign In

MRI of the liver to measure iron overload in patient with long term liver and blood disorders.

To evaluate the role of MRI liver in assessing hepatic iron overload in patient with systemic and chronic liver disease. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103535
Enrollment
40
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of any age and gender with clinical suspicion or diagnosis of hepatic iron overload. 2.Patients diagnosed with systemic and chronic liver diseases 3.Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to MRI (e.g., pacemakers, metallic implants). 2.Pregnant patients. 3.Patients with severe claustrophobia or inability to cooperate. 4.Patients who refuse to participate.

Design outcomes

Primary

MeasureTime frame
Usefulness of MRI as a reliable and non-invasive method for evaluating liver iron levels.Timepoint: Assessment will be done at 4 weeks—

Secondary

MeasureTime frame
1To evaluate MRI characteristic of liver parenchyma on different MRI sequence and to identify and place Region of interest (ROI) within the liver parenchyma, avoiding vessels and artefactsTimepoint: 1 YEAR 8 MONTH—

Countries

India

Contacts

Public ContactDr. Shrishty Agrawal

Datta Meghe Institute of Higher Education and Research

drphparihar@gmail.com9422104957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026